CancerWorld shared a post on LinkedIn:
“55% Reduction in Cancer Recurrence? Aspirin Shows Promise!
A daily low-dose aspirin for three years reduced colorectal cancer recurrence by 55% in patients with a mutated PI3K gene.
New research suggests that adjuvant low-dose aspirin could be a simple, low-cost strategy to help prevent recurrence in high-risk patients.
Could this widely available pill become a game-changer in cancer care?
More posts featuring CancerWorld.